On April 23, 2025, Artelo Biosciences, Inc. was notified by Nasdaq that it is not complying with the minimum $1.00 bid price requirement for continued listing and has until October 20, 2025, to regain compliance. If compliance is not met, the company may face delisting and could consider actions like a reverse stock split.